Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5848203 | 6729488 | I | 5848203-3 | 20080708 | 20080808 | 20080818 | EXP | B0532498A | GLAXOSMITHKLINE | 39 | YR | F | Y | 20080818 | CN | FRANCE |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
5848203 | 1010318242 | PS | ZIAGEN | 1 | ORAL | 300MG TWICE PER DAY | UNKNOWN | 20977 | |||
5848203 | 1010318243 | SS | TMC125 | 2 | ORAL | 200MG TWICE PER DAY | UNKNOWN | ||||
5848203 | 1010318244 | SS | RALTEGRAVIR | 2 | ORAL | 400MG TWICE PER DAY | UNKNOWN | ||||
5848203 | 1010318245 | SS | VIREAD | 1 | ORAL | 300MG PER DAY | UNKNOWN |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
5848203 | 1010318242 | ANTIRETROVIRAL THERAPY |
5848203 | 1010318243 | ANTIRETROVIRAL THERAPY |
5848203 | 1010318244 | ANTIRETROVIRAL THERAPY |
5848203 | 1010318245 | ANTIRETROVIRAL THERAPY |
Outcome of event
Event ID | OUTC COD |
---|---|
5848203 | HO |
Reactions reported
Event ID | PT |
---|---|
5848203 | ASTHENIA |
5848203 | CHILLS |
5848203 | GENERALISED ERYTHEMA |
5848203 | HEADACHE |
5848203 | PRURITUS |
5848203 | SKIN LESION |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
5848203 | 1010318242 | 20080630 | 20080709 | 10 | DAY |
5848203 | 1010318243 | 20080630 | 20080709 | 10 | DAY |
5848203 | 1010318244 | 20080630 | 20080709 | 10 | DAY |
5848203 | 1010318245 | 20080630 | 20080709 | 10 | DAY |